Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung Cancer

NCT03166254 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lost funding

Conditions

Non Small Cell Lung Cancer
NSCLC
Non-small Cell Lung Cancer
Small Cell Lung Extensive Stage

Interventions

DRUG: Pembrolizumab
BIOLOGICAL: NEO-PV-01 vaccine
PROCEDURE: Biopsy
DRUG: Poly ICLC
PROCEDURE: Leukapheresis
PROCEDURE: Peripheral blood samples

Sponsor

Washington University School of Medicine

Collaborators

[object Object]